201 related articles for article (PubMed ID: 33481184)
1. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
Tanaka Y; Ohno T; Kadonaga T; Kidokoro Y; Wakahara M; Nosaka K; Sakabe T; Suzuki Y; Nakamura H; Umekita Y
Breast Cancer; 2021 Jul; 28(4):822-828. PubMed ID: 33481184
[TBL] [Abstract][Full Text] [Related]
2. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
[TBL] [Abstract][Full Text] [Related]
3. Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung.
Yurugi Y; Wakahara M; Matsuoka Y; Sakabe T; Kubouchi Y; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Jan; 37(1):207-213. PubMed ID: 28011493
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
Schoppmann SF; Berghoff A; Dinhof C; Jakesz R; Gnant M; Dubsky P; Jesch B; Heinzl H; Birner P
Breast Cancer Res Treat; 2012 Jul; 134(1):237-44. PubMed ID: 22350732
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M
Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904
[TBL] [Abstract][Full Text] [Related]
7. Stromal podoplanin expression and its clinicopathological role in breast carcinoma.
Kumcu E; Unverdi H; Kaymaz E; Oral O; Turkbey D; Hucmenoglu S
Malays J Pathol; 2018 Aug; 40(2):137-142. PubMed ID: 30173230
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.
Nakasone S; Mimaki S; Ichikawa T; Aokage K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Goto K; Tsuchihara K; Ishii G
J Cancer Res Clin Oncol; 2018 May; 144(5):893-900. PubMed ID: 29511884
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
Suchanski J; Tejchman A; Zacharski M; Piotrowska A; Grzegrzolka J; Chodaczek G; Nowinska K; Rys J; Dziegiel P; Kieda C; Ugorski M
PLoS One; 2017; 12(9):e0184970. PubMed ID: 28938000
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus.
Schoppmann SF; Jesch B; Riegler MF; Maroske F; Schwameis K; Jomrich G; Birner P
Clin Exp Metastasis; 2013 Apr; 30(4):441-6. PubMed ID: 23161183
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
13. CD61+ and CAF+ were found to be good prognosis factors for invasive breast cancer patients.
Cai D; Wu X; Hong T; Mao Y; Ge X; Hua D
Pathol Res Pract; 2017 Oct; 213(10):1296-1301. PubMed ID: 28935175
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
15. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.
Tan QX; Qin QH; Yang WP; Mo QG; Wei CY
Int J Clin Exp Pathol; 2014; 7(10):6862-70. PubMed ID: 25400769
[TBL] [Abstract][Full Text] [Related]
17. Triple-negative, basal marker-expressing, and high-grade breast carcinomas are characterized by high lymphatic vessel density and the expression of podoplanin in stromal fibroblasts.
Niemiec JA; Adamczyk A; Ambicka A; Mucha-Małecka A; M Wysocki W; Ryś J
Appl Immunohistochem Mol Morphol; 2014 Jan; 22(1):10-6. PubMed ID: 23455186
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of CD9 expression differs between tumour cells and stromal immune cells, and depends on the molecular subtype of the invasive breast carcinoma.
Kwon HJ; Choi JE; Kang SH; Son Y; Bae YK
Histopathology; 2017 Jun; 70(7):1155-1165. PubMed ID: 28178752
[TBL] [Abstract][Full Text] [Related]
19. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers.
Ono M; Tsuda H; Yunokawa M; Yonemori K; Shimizu C; Tamura K; Kinoshita T; Fujiwara Y
Breast Cancer; 2015 Mar; 22(2):141-52. PubMed ID: 23584595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
